Clinical investigation of antiarrhythmic devices

A statement for healthcare professionals from a joint task force of the American Heart Association, the North American Society of Pacing and Electrophysiology, the American College of Cardiology, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology

S. Saksena, A. E. Epstein, R. Lazzara, J. D. Maloney, D. P. Zipes, D. G. Benditt, A. J. Camm, M. J. Domanski, John Devens Fisher, B. J. Gersh, G. A. Lamas, M. H. Lehmann, D. E. Nickelson, E. N. Prystowsky, D. G. Wyse

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The goal of radiofrequency catheter ablation and the criterion for efficacy is the elimination of arrhythmogenic myocardium. The application of radiofrequency current in the heart clearly results in lower morbidity and mortality rates than thoracic and cardiac surgical procedures in general, and comparisons of therapy with radiofrequency catheter ablation and therapy with thoracic and cardiac surgical procedures in randomized clinical trials is unwarranted. Trials of radiofrequency catheter ablation versus medical or implantable cardioverter-defibrillator therapy may be indicated in certain conditions, such as ventricular tachycardia associated with coronary artery disease. Randomized trials are recommended for new and radical departures in technology that aim to accomplish the same goals as radiofrequency catheter ablation. Surveillance using registries and/or databases is necessary in the assessment of long-term safety and efficacy.

Original languageEnglish (US)
Pages (from-to)2097-2109
Number of pages13
JournalCirculation
Volume91
Issue number7
StatePublished - 1995
Externally publishedYes

Fingerprint

Catheter Ablation
Electrophysiology
Advisory Committees
Cardiac Arrhythmias
Thoracic Surgical Procedures
Joints
Cardiac Surgical Procedures
Delivery of Health Care
Equipment and Supplies
Implantable Defibrillators
Ventricular Tachycardia
Registries
Coronary Artery Disease
Myocardium
Therapeutics
Randomized Controlled Trials
Databases
Technology
Morbidity
Safety

Keywords

  • AHA Medical/Scientific Statements
  • antiarrhythmia agents
  • arrhythmias
  • pacemakers

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical investigation of antiarrhythmic devices : A statement for healthcare professionals from a joint task force of the American Heart Association, the North American Society of Pacing and Electrophysiology, the American College of Cardiology, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology. / Saksena, S.; Epstein, A. E.; Lazzara, R.; Maloney, J. D.; Zipes, D. P.; Benditt, D. G.; Camm, A. J.; Domanski, M. J.; Fisher, John Devens; Gersh, B. J.; Lamas, G. A.; Lehmann, M. H.; Nickelson, D. E.; Prystowsky, E. N.; Wyse, D. G.

In: Circulation, Vol. 91, No. 7, 1995, p. 2097-2109.

Research output: Contribution to journalArticle

Saksena, S. ; Epstein, A. E. ; Lazzara, R. ; Maloney, J. D. ; Zipes, D. P. ; Benditt, D. G. ; Camm, A. J. ; Domanski, M. J. ; Fisher, John Devens ; Gersh, B. J. ; Lamas, G. A. ; Lehmann, M. H. ; Nickelson, D. E. ; Prystowsky, E. N. ; Wyse, D. G. / Clinical investigation of antiarrhythmic devices : A statement for healthcare professionals from a joint task force of the American Heart Association, the North American Society of Pacing and Electrophysiology, the American College of Cardiology, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology. In: Circulation. 1995 ; Vol. 91, No. 7. pp. 2097-2109.
@article{8bcf35a9843a45898767c34ff73ed9f7,
title = "Clinical investigation of antiarrhythmic devices: A statement for healthcare professionals from a joint task force of the American Heart Association, the North American Society of Pacing and Electrophysiology, the American College of Cardiology, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology",
abstract = "The goal of radiofrequency catheter ablation and the criterion for efficacy is the elimination of arrhythmogenic myocardium. The application of radiofrequency current in the heart clearly results in lower morbidity and mortality rates than thoracic and cardiac surgical procedures in general, and comparisons of therapy with radiofrequency catheter ablation and therapy with thoracic and cardiac surgical procedures in randomized clinical trials is unwarranted. Trials of radiofrequency catheter ablation versus medical or implantable cardioverter-defibrillator therapy may be indicated in certain conditions, such as ventricular tachycardia associated with coronary artery disease. Randomized trials are recommended for new and radical departures in technology that aim to accomplish the same goals as radiofrequency catheter ablation. Surveillance using registries and/or databases is necessary in the assessment of long-term safety and efficacy.",
keywords = "AHA Medical/Scientific Statements, antiarrhythmia agents, arrhythmias, pacemakers",
author = "S. Saksena and Epstein, {A. E.} and R. Lazzara and Maloney, {J. D.} and Zipes, {D. P.} and Benditt, {D. G.} and Camm, {A. J.} and Domanski, {M. J.} and Fisher, {John Devens} and Gersh, {B. J.} and Lamas, {G. A.} and Lehmann, {M. H.} and Nickelson, {D. E.} and Prystowsky, {E. N.} and Wyse, {D. G.}",
year = "1995",
language = "English (US)",
volume = "91",
pages = "2097--2109",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Clinical investigation of antiarrhythmic devices

T2 - A statement for healthcare professionals from a joint task force of the American Heart Association, the North American Society of Pacing and Electrophysiology, the American College of Cardiology, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology

AU - Saksena, S.

AU - Epstein, A. E.

AU - Lazzara, R.

AU - Maloney, J. D.

AU - Zipes, D. P.

AU - Benditt, D. G.

AU - Camm, A. J.

AU - Domanski, M. J.

AU - Fisher, John Devens

AU - Gersh, B. J.

AU - Lamas, G. A.

AU - Lehmann, M. H.

AU - Nickelson, D. E.

AU - Prystowsky, E. N.

AU - Wyse, D. G.

PY - 1995

Y1 - 1995

N2 - The goal of radiofrequency catheter ablation and the criterion for efficacy is the elimination of arrhythmogenic myocardium. The application of radiofrequency current in the heart clearly results in lower morbidity and mortality rates than thoracic and cardiac surgical procedures in general, and comparisons of therapy with radiofrequency catheter ablation and therapy with thoracic and cardiac surgical procedures in randomized clinical trials is unwarranted. Trials of radiofrequency catheter ablation versus medical or implantable cardioverter-defibrillator therapy may be indicated in certain conditions, such as ventricular tachycardia associated with coronary artery disease. Randomized trials are recommended for new and radical departures in technology that aim to accomplish the same goals as radiofrequency catheter ablation. Surveillance using registries and/or databases is necessary in the assessment of long-term safety and efficacy.

AB - The goal of radiofrequency catheter ablation and the criterion for efficacy is the elimination of arrhythmogenic myocardium. The application of radiofrequency current in the heart clearly results in lower morbidity and mortality rates than thoracic and cardiac surgical procedures in general, and comparisons of therapy with radiofrequency catheter ablation and therapy with thoracic and cardiac surgical procedures in randomized clinical trials is unwarranted. Trials of radiofrequency catheter ablation versus medical or implantable cardioverter-defibrillator therapy may be indicated in certain conditions, such as ventricular tachycardia associated with coronary artery disease. Randomized trials are recommended for new and radical departures in technology that aim to accomplish the same goals as radiofrequency catheter ablation. Surveillance using registries and/or databases is necessary in the assessment of long-term safety and efficacy.

KW - AHA Medical/Scientific Statements

KW - antiarrhythmia agents

KW - arrhythmias

KW - pacemakers

UR - http://www.scopus.com/inward/record.url?scp=0028944649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028944649&partnerID=8YFLogxK

M3 - Article

VL - 91

SP - 2097

EP - 2109

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 7

ER -